Heavy Volume And Pre-Market Movement For Cell Therapeutics (CTIC)
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.
Trade-Ideas LLC identified
(
) as a pre-market mover with heavy volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Cell Therapeutics as such a stock due to the following factors:
- CTIC has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $12.0 million.
- CTIC traded 391,830 shares today in the pre-market hours as of 7:43 AM, representing 10.3% of its average daily volume.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in CTIC with the Ticky from Trade-Ideas. See the FREE profile for CTIC NOW at Trade-Ideas
More details on CTIC:
CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer.
The average volume for Cell Therapeutics has been 3.7 million shares per day over the past 30 days. Cell has a market cap of $440.5 million and is part of the health care sector and drugs industry. The stock has a beta of 0.96 and a short float of 11.2% with 3.14 days to cover. Shares are up 53.9% year-to-date as of the close of trading on Tuesday.
null